Regina Wong has extensive experience in clinical and regulatory affairs, business development, and medical research. Regina has a strong track record of successful FDA submissions, patent portfolio management, and securing funding from various investors. Regina has a background in life sciences with a doctoral degree in cancer biology and has published several papers in reputable journals. Regina has also mentored university students and collaborated with scientists globally.
January 1, 2024 - present
November, 2021
June, 2020